These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37724258)

  • 1. Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives.
    Liu L; Chen J
    Med Rev (2021); 2022 Dec; 2(6):555-569. PubMed ID: 37724258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications.
    Shin C; Kim SS; Jo YH
    Mol Ther Oncolytics; 2021 Sep; 22():166-179. PubMed ID: 34514097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Next Generation Antibody Therapeutics Using Bispecific Antibody Technology].
    Igawa T
    Yakugaku Zasshi; 2017; 137(7):831-836. PubMed ID: 28674296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics.
    Runcie K; Budman DR; John V; Seetharamu N
    Mol Med; 2018 Sep; 24(1):50. PubMed ID: 30249178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
    Cho SF; Anderson KC; Tai YT
    Front Immunol; 2018; 9():1821. PubMed ID: 30147690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
    Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
    MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trispecific antibodies for cancer immunotherapy.
    Yao Y; Hu Y; Wang F
    Immunology; 2023 Aug; 169(4):389-399. PubMed ID: 36855956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy.
    Li T; Wang X; Niu M; Wang M; Zhou J; Wu K; Yi M
    Front Immunol; 2023; 14():1196970. PubMed ID: 37520520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in multiple myeloma.
    Jadoon Y; Siddiqui MA
    Cancer Treat Res Commun; 2021; 29():100468. PubMed ID: 34653747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
    Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
    MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.
    Mihăilă RG
    Recent Pat Anticancer Drug Discov; 2020; 15(4):272-292. PubMed ID: 32981510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody therapeutics and immunoregulation in cancer and autoimmune disease.
    Yasunaga M
    Semin Cancer Biol; 2020 Aug; 64():1-12. PubMed ID: 31181267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-clinical safety evaluations of next-generation therapeutic antibodies].
    Nihira K
    Nihon Yakurigaku Zasshi; 2022; 157(6):458-463. PubMed ID: 36328561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in monoclonal antibody-based immunotherapy for cancer treatment].
    Guo Y
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):857-70. PubMed ID: 26672362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody and antibody fragments for cancer immunotherapy.
    Chen W; Yuan Y; Jiang X
    J Control Release; 2020 Dec; 328():395-406. PubMed ID: 32853733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bispecific antibodies for cancer immunotherapy: Current perspectives.
    Müller D; Kontermann RE
    BioDrugs; 2010 Apr; 24(2):89-98. PubMed ID: 20199124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific antibodies for viral immunotherapy.
    Nyakatura EK; Soare AY; Lai JR
    Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.